However, since in horses, some benign tumors can express this biomarker and some malignant tumors may not express it, we agree with the opinion of Kuźbicki et al. (2014) that although COX-2 may be used as an aid in the diagnosis, it may not be very reliable [55]. This evidence concerns the gene PTGS2 and benign neoplasm.